ID   SIAL_HUMAN              Reviewed;         317 AA.
AC   P21815;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 4.
DT   11-DEC-2019, entry version 153.
DE   RecName: Full=Bone sialoprotein 2;
DE   AltName: Full=Bone sialoprotein II;
DE            Short=BSP II;
DE   AltName: Full=Cell-binding sialoprotein;
DE   AltName: Full=Integrin-binding sialoprotein;
DE   Flags: Precursor;
GN   Name=IBSP; Synonyms=BNSP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS GLY-213; GLY-219 AND VAL-268.
RX   PubMed=2404984;
RA   Fisher L.W., McBride O.W., Termine J.D., Young M.F.;
RT   "Human bone sialoprotein. Deduced protein sequence and chromosomal
RT   localization.";
RL   J. Biol. Chem. 265:2347-2351(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLU-195; GLY-213; GLY-219
RP   AND ASP-270.
RX   PubMed=8406493; DOI=10.1006/geno.1993.1340;
RA   Kerr J.M., Fisher L.W., Termine J.D., Wang M.G., McBride W., Young M.F.;
RT   "The human bone sialoprotein gene (IBSP): genomic localization and
RT   characterization.";
RL   Genomics 17:408-415(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLU-195; GLY-213 AND
RP   ASP-270.
RX   PubMed=8061918; DOI=10.1016/0945-053x(94)90027-2;
RA   Kim R.H., Shapiro H.S., Li J.J., Wrana J.L., Sodek J.;
RT   "Characterization of the human bone sialoprotein (BSP) gene and its
RT   promoter sequence.";
RL   Matrix Biol. 14:31-40(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE, AND CHARACTERIZATION.
RX   PubMed=3597437;
RA   Fisher L.W., Hawkins G.R., Tuross N., Termine J.D.;
RT   "Purification and partial characterization of small proteoglycans I and II,
RT   bone sialoproteins I and II, and osteonectin from the mineral compartment
RT   of developing human bone.";
RL   J. Biol. Chem. 262:9702-9708(1987).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE, GLYCOSYLATION AT THR-119; THR-122; THR-227;
RP   THR-228; THR-229; THR-238 AND THR-239, STRUCTURE OF CARBOHYDRATE, VARIANT
RP   GLY-213, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=11459848; DOI=10.1074/jbc.m105689200;
RA   Wuttke M., Muller S., Nitsche D.P., Paulsson M., Hanisch F.G., Maurer P.;
RT   "Structural characterization of human recombinant and bone-derived bone
RT   sialoprotein. Functional implications for cell attachment and
RT   hydroxyapatite binding.";
RL   J. Biol. Chem. 276:36839-36848(2001).
RN   [7]
RP   PHOSPHORYLATION AT SER-31, SULFATION AT TYR-313 AND TYR-314, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=11669636; DOI=10.1021/bi010887r;
RA   Zaia J., Boynton R., Heinegard D., Barry F.;
RT   "Posttranslational modifications to human bone sialoprotein determined by
RT   mass spectrometry.";
RL   Biochemistry 40:12983-12991(2001).
CC   -!- FUNCTION: Binds tightly to hydroxyapatite. Appears to form an integral
CC       part of the mineralized matrix. Probably important to cell-matrix
CC       interaction. Promotes Arg-Gly-Asp-dependent cell attachment.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- PTM: N-glycosylated; glycans consist of sialylated and core-fucosylated
CC       bi-, tri- and tetraantennary chains. {ECO:0000269|PubMed:11459848}.
CC   -!- PTM: O-glycosylated at eight sites; mucin-type glycans contain Gal,
CC       GlcNAc, GalNAc and terminal NeuAc. {ECO:0000269|PubMed:11459848}.
CC   -!- PTM: Sulfated on either Tyr-313 or Tyr-314.
CC       {ECO:0000269|PubMed:11669636}.
CC   -!- MISCELLANEOUS: It is possible that the segments of clustered carboxyl
CC       groups mediate the strong binding to hydroxyapatite.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J05213; AAC95490.1; -; mRNA.
DR   EMBL; L09558; AAA60549.1; -; Genomic_DNA.
DR   EMBL; L09554; AAA60549.1; JOINED; Genomic_DNA.
DR   EMBL; L09555; AAA60549.1; JOINED; Genomic_DNA.
DR   EMBL; L09556; AAA60549.1; JOINED; Genomic_DNA.
DR   EMBL; L09557; AAA60549.1; JOINED; Genomic_DNA.
DR   EMBL; L24759; AAC37560.1; -; Genomic_DNA.
DR   EMBL; L24757; AAC37560.1; JOINED; Genomic_DNA.
DR   EMBL; AC093768; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS3624.1; -.
DR   PIR; A35043; GEHUS.
DR   RefSeq; NP_004958.2; NM_004967.3.
DR   SMR; P21815; -.
DR   IntAct; P21815; 1.
DR   STRING; 9606.ENSP00000226284; -.
DR   iPTMnet; P21815; -.
DR   PhosphoSitePlus; P21815; -.
DR   BioMuta; IBSP; -.
DR   DMDM; 317373545; -.
DR   PaxDb; P21815; -.
DR   PeptideAtlas; P21815; -.
DR   PRIDE; P21815; -.
DR   ProteomicsDB; 53929; -.
DR   DNASU; 3381; -.
DR   Ensembl; ENST00000226284; ENSP00000226284; ENSG00000029559.
DR   GeneID; 3381; -.
DR   KEGG; hsa:3381; -.
DR   UCSC; uc003hqx.5; human.
DR   CTD; 3381; -.
DR   DisGeNET; 3381; -.
DR   EuPathDB; HostDB:ENSG00000029559.6; -.
DR   GeneCards; IBSP; -.
DR   HGNC; HGNC:5341; IBSP.
DR   MIM; 147563; gene.
DR   neXtProt; NX_P21815; -.
DR   OpenTargets; ENSG00000029559; -.
DR   PharmGKB; PA29590; -.
DR   eggNOG; KOG1181; Eukaryota.
DR   eggNOG; ENOG4111M3T; LUCA.
DR   GeneTree; ENSGT00390000002485; -.
DR   HOGENOM; HOG000234824; -.
DR   InParanoid; P21815; -.
DR   KO; K06253; -.
DR   OMA; QDYYYHQ; -.
DR   OrthoDB; 1565775at2759; -.
DR   PhylomeDB; P21815; -.
DR   TreeFam; TF338678; -.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   SIGNOR; P21815; -.
DR   ChiTaRS; IBSP; human.
DR   GeneWiki; Bone_sialoprotein; -.
DR   GenomeRNAi; 3381; -.
DR   Pharos; P21815; Tbio.
DR   PRO; PR:P21815; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; P21815; protein.
DR   Bgee; ENSG00000029559; Expressed in 157 organ(s), highest expression level in tibia.
DR   Genevisible; P21815; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; ISS:UniProtKB.
DR   GO; GO:0005178; F:integrin binding; IMP:CAFA.
DR   GO; GO:0030282; P:bone mineralization; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; ISS:UniProtKB.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; ISS:UniProtKB.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IMP:CAFA.
DR   DisProt; DP00332; -.
DR   InterPro; IPR008412; BSP_II.
DR   PANTHER; PTHR10345; PTHR10345; 1.
DR   Pfam; PF05432; BSP_II; 1.
PE   1: Evidence at protein level;
KW   Biomineralization; Cell adhesion; Direct protein sequencing; Glycoprotein;
KW   Phosphoprotein; Polymorphism; Reference proteome; Secreted; Sialic acid;
KW   Signal; Sulfation.
FT   SIGNAL          1..16
FT   CHAIN           17..317
FT                   /note="Bone sialoprotein 2"
FT                   /id="PRO_0000020330"
FT   MOTIF           286..288
FT                   /note="Cell attachment site"
FT   COMPBIAS        65..173
FT                   /note="Asp/Glu-rich (acidic)"
FT   COMPBIAS        76..83
FT                   /note="Poly-Glu"
FT   COMPBIAS        151..158
FT                   /note="Poly-Glu"
FT   MOD_RES         31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:11669636"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q28862"
FT   MOD_RES         74
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q28862"
FT   MOD_RES         75
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q28862"
FT   MOD_RES         94
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q28862"
FT   MOD_RES         100
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q28862"
FT   MOD_RES         149
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q28862"
FT   MOD_RES         280
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q28862"
FT   MOD_RES         313
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000269|PubMed:11669636"
FT   MOD_RES         314
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000269|PubMed:11669636"
FT   CARBOHYD        104
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        119
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000305|PubMed:11459848"
FT   CARBOHYD        122
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000305|PubMed:11459848"
FT   CARBOHYD        177
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        182
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        190
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        227
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000305|PubMed:11459848"
FT   CARBOHYD        228
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000305|PubMed:11459848"
FT   CARBOHYD        229
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000305|PubMed:11459848"
FT   CARBOHYD        238
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000305|PubMed:11459848"
FT   CARBOHYD        239
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000305|PubMed:11459848"
FT   VARIANT         195
FT                   /note="G -> E (in dbSNP:rs1054627)"
FT                   /evidence="ECO:0000269|PubMed:8061918,
FT                   ECO:0000269|PubMed:8406493"
FT                   /id="VAR_058014"
FT   VARIANT         213
FT                   /note="D -> G (in dbSNP:rs13144371)"
FT                   /evidence="ECO:0000269|PubMed:11459848,
FT                   ECO:0000269|PubMed:2404984, ECO:0000269|PubMed:8061918,
FT                   ECO:0000269|PubMed:8406493"
FT                   /id="VAR_058015"
FT   VARIANT         219
FT                   /note="R -> G (in dbSNP:rs17013181)"
FT                   /evidence="ECO:0000269|PubMed:2404984,
FT                   ECO:0000269|PubMed:8406493"
FT                   /id="VAR_058016"
FT   VARIANT         256
FT                   /note="T -> A (in dbSNP:rs17013182)"
FT                   /id="VAR_056579"
FT   VARIANT         268
FT                   /note="A -> V (in dbSNP:rs1054628)"
FT                   /evidence="ECO:0000269|PubMed:2404984"
FT                   /id="VAR_056580"
FT   VARIANT         270
FT                   /note="E -> D (in dbSNP:rs1054629)"
FT                   /evidence="ECO:0000269|PubMed:8061918,
FT                   ECO:0000269|PubMed:8406493"
FT                   /id="VAR_058017"
FT   CONFLICT        94
FT                   /note="S -> L (in Ref. 3; AAC37560)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   317 AA;  35148 MW;  736CB6B8C3716FE7 CRC64;
     MKTALILLSI LGMACAFSMK NLHRRVKIED SEENGVFKYR PRYYLYKHAY FYPHLKRFPV
     QGSSDSSEEN GDDSSEEEEE EEETSNEGEN NEESNEDEDS EAENTTLSAT TLGYGEDATP
     GTGYTGLAAI QLPKKAGDIT NKATKEKESD EEEEEEEEGN ENEESEAEVD ENEQGINGTS
     TNSTEAENGN GSSGGDNGEE GEEESVTGAN AEDTTETGRQ GKGTSKTTTS PNGGFEPTTP
     PQVYRTTSPP FGKTTTVEYE GEYEYTGANE YDNGYEIYES ENGEPRGDNY RAYEDEYSYF
     KGQGYDGYDG QNYYHHQ
//
